<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Industry Updates - CamBioLogics</title>
    <meta name="description" content="Latest news and updates in cell & gene therapy, AI drug discovery, regulatory developments, and upcoming industry events curated by CamBioLogics.">
    <link href="https://fonts.googleapis.com/css2?family=Playfair+Display:wght@400;600;700;800&family=Cormorant+Garamond:wght@300;400;500;600&display=swap" rel="stylesheet">
    <style>
        :root {
            --deep-navy: #0f1419;
            --rich-blue: #1a3a52;
            --teal-accent: #2c5f6f;
            --copper: #b87333;
            --gold: #d4af37;
            --soft-cream: #f5f1ed;
            --ivory: #f0ece6;
            --midnight: #0a0e14;
            --sage: #8b9d83;
            --gradient-primary: linear-gradient(135deg, #1a3a52 0%, #2c5f6f 50%, #3d7a8a 100%);
            --gradient-accent: linear-gradient(135deg, #b87333 0%, #d4af37 50%, #b87333 100%);
        }

        * { margin: 0; padding: 0; box-sizing: border-box; }

        body {
            font-family: 'Cormorant Garamond', serif;
            color: var(--rich-blue);
            background: var(--ivory);
            line-height: 1.8;
            overflow-x: hidden;
        }

        .molecular-bg {
            position: fixed; top: 0; left: 0; width: 100%; height: 100%; z-index: -1; opacity: 0.03;
            background-image:
                radial-gradient(circle at 20% 50%, var(--rich-blue) 3px, transparent 3px),
                radial-gradient(circle at 80% 80%, var(--teal-accent) 2px, transparent 2px),
                radial-gradient(circle at 40% 20%, var(--copper) 2px, transparent 2px);
            background-size: 120px 80px, 180px 120px, 100px 70px;
            animation: molecularFloat 80s linear infinite;
        }

        @keyframes molecularFloat {
            0% { transform: translate(0, 0) rotate(0deg); }
            100% { transform: translate(-30px, -30px) rotate(360deg); }
        }

        /* ‚îÄ‚îÄ‚îÄ Navigation ‚îÄ‚îÄ‚îÄ */
        nav {
            position: fixed; top: 0; left: 0; right: 0;
            background: rgba(250, 250, 248, 0.97);
            backdrop-filter: blur(15px);
            padding: 1.5rem 4rem;
            display: flex; justify-content: space-between; align-items: center;
            z-index: 1000;
            box-shadow: 0 2px 30px rgba(26, 58, 82, 0.1);
            animation: slideDown 0.8s ease-out;
            border-bottom: 1px solid rgba(184, 115, 51, 0.15);
        }

        @keyframes slideDown {
            from { transform: translateY(-100%); opacity: 0; }
            to { transform: translateY(0); opacity: 1; }
        }

        .nav-brand {
            display: flex; flex-direction: column; align-items: flex-start; text-decoration: none;
        }
        .nav-brand img { height: 42px; width: auto; }
        .nav-tagline {
            font-size: 0.55rem; font-weight: 600; letter-spacing: 0.15em;
            text-transform: uppercase; color: #2c5f6f; margin-top: 2px;
            font-family: 'Cormorant Garamond', serif;
        }
        .nav-tagline span { color: #b87333; }

        .nav-links { display: flex; gap: 3rem; list-style: none; align-items: center; }
        .nav-links a {
            text-decoration: none; color: var(--rich-blue); font-weight: 500; font-size: 1.05rem;
            position: relative; transition: all 0.4s ease; letter-spacing: 0.5px;
        }
        .nav-links a::after {
            content: ''; position: absolute; bottom: -5px; left: 0; width: 0; height: 2px;
            background: var(--gradient-accent); transition: width 0.4s ease;
        }
        .nav-links a:hover { color: var(--copper); transform: translateY(-2px); }
        .nav-links a:hover::after { width: 100%; }
        .nav-links a.active { color: var(--copper); }
        .nav-links a.active::after { width: 100%; }

        .nav-links a.nav-cta-updates {
            background: var(--gradient-accent);
            color: white !important; -webkit-text-fill-color: white;
            padding: 0.5rem 1.5rem; border-radius: 25px; font-weight: 600;
            letter-spacing: 0.3px; transition: all 0.4s ease;
            box-shadow: 0 2px 10px rgba(184, 115, 51, 0.25);
        }
        .nav-links a.nav-cta-updates:hover {
            transform: translateY(-2px); box-shadow: 0 4px 18px rgba(184, 115, 51, 0.4);
        }
        .nav-links a.nav-cta-updates::after { display: none; }

        .dropdown { position: relative; }
        .dropdown-content {
            display: none; position: absolute; top: 100%; left: -20px;
            background: rgba(240, 236, 230, 0.98); backdrop-filter: blur(10px);
            min-width: 320px; box-shadow: 0 10px 40px rgba(26, 58, 82, 0.15);
            border-radius: 12px; overflow: hidden; padding: 0.5rem 0;
            border: 1px solid rgba(184, 115, 51, 0.1); z-index: 100;
        }
        .dropdown:hover .dropdown-content { display: block; }
        .dropdown-content a {
            display: block; padding: 0.6rem 1.2rem; font-size: 0.95rem;
            color: var(--rich-blue); transition: all 0.3s;
        }
        .dropdown-content a:hover { background: rgba(184, 115, 51, 0.08); color: var(--copper); }
        .dropdown-content a::after { display: none; }
        .dropdown-flagship {
            display: flex !important; justify-content: space-between; align-items: center;
            padding: 0.8rem 1.2rem !important;
            background: linear-gradient(135deg, rgba(26, 58, 82, 0.05), rgba(44, 95, 111, 0.08));
            border-bottom: 1px solid rgba(184, 115, 51, 0.12);
        }
        .flagship-name { font-family: 'Playfair Display', serif; font-weight: 700; font-size: 1rem; display: block; }
        .flagship-desc { font-size: 0.8rem; opacity: 0.7; display: block; margin-top: 2px; }
        .flagship-badges { display: flex; gap: 0.4rem; }
        .flagship-badge {
            background: var(--gradient-accent); color: white; font-size: 0.65rem; padding: 0.15rem 0.5rem;
            border-radius: 10px; font-weight: 600;
        }
        .flagship-badge-outline {
            border: 1px solid var(--copper); color: var(--copper); font-size: 0.65rem;
            padding: 0.15rem 0.5rem; border-radius: 10px; font-weight: 600;
        }
        .dropdown-divider-label {
            padding: 0.4rem 1.2rem; font-size: 0.7rem; text-transform: uppercase;
            letter-spacing: 0.1em; color: var(--teal-accent); opacity: 0.7; font-weight: 600;
        }

        /* ‚îÄ‚îÄ‚îÄ Hero ‚îÄ‚îÄ‚îÄ */
        .hero {
            padding: 10rem 4rem 4rem; text-align: center; position: relative; overflow: hidden;
            background: linear-gradient(180deg, rgba(26,58,82,0.04) 0%, transparent 100%);
        }
        .hero h1 {
            font-family: 'Playfair Display', serif; font-size: 3.2rem; font-weight: 800;
            color: var(--rich-blue); margin-bottom: 1rem; letter-spacing: -0.02em;
        }
        .hero h1 .highlight {
            background: var(--gradient-accent); -webkit-background-clip: text;
            -webkit-text-fill-color: transparent; background-clip: text;
        }
        .hero-subtitle {
            font-size: 1.25rem; max-width: 700px; margin: 0 auto; color: var(--teal-accent);
            line-height: 1.6;
        }

        /* ‚îÄ‚îÄ‚îÄ Controls ‚îÄ‚îÄ‚îÄ */
        .controls {
            max-width: 1100px; margin: 0 auto 2.5rem; padding: 0 2rem;
        }
        .search-box {
            width: 100%; padding: 1rem 1.5rem; font-size: 1.1rem;
            font-family: 'Cormorant Garamond', serif;
            border: 2px solid rgba(26, 58, 82, 0.12); border-radius: 12px;
            background: white; color: var(--rich-blue); outline: none;
            transition: border-color 0.3s, box-shadow 0.3s;
            margin-bottom: 1.25rem;
        }
        .search-box:focus {
            border-color: var(--copper);
            box-shadow: 0 0 0 3px rgba(184, 115, 51, 0.12);
        }
        .search-box::placeholder { color: rgba(26, 58, 82, 0.4); }

        .filter-chips {
            display: flex; flex-wrap: wrap; gap: 0.6rem; align-items: center;
        }
        .filter-chip {
            padding: 0.45rem 1.1rem; border-radius: 20px; border: 1.5px solid rgba(26, 58, 82, 0.15);
            background: white; color: var(--rich-blue); font-size: 0.9rem;
            font-family: 'Cormorant Garamond', serif; font-weight: 500;
            cursor: pointer; transition: all 0.3s; user-select: none;
        }
        .filter-chip:hover { border-color: var(--copper); color: var(--copper); }
        .filter-chip.active {
            background: var(--gradient-accent); color: white; border-color: transparent;
            box-shadow: 0 2px 8px rgba(184, 115, 51, 0.25);
        }
        .sort-btn {
            margin-left: auto; padding: 0.45rem 1.1rem; border-radius: 20px;
            border: 1.5px solid rgba(26, 58, 82, 0.15); background: white;
            color: var(--rich-blue); font-size: 0.9rem; font-family: 'Cormorant Garamond', serif;
            font-weight: 500; cursor: pointer; transition: all 0.3s;
        }
        .sort-btn:hover { border-color: var(--copper); color: var(--copper); }

        /* ‚îÄ‚îÄ‚îÄ Section headings ‚îÄ‚îÄ‚îÄ */
        .section-block {
            max-width: 1100px; margin: 0 auto 3rem; padding: 0 2rem;
        }
        .section-heading {
            font-family: 'Playfair Display', serif; font-size: 1.8rem; font-weight: 700;
            color: var(--rich-blue); margin-bottom: 1.25rem; padding-bottom: 0.5rem;
            border-bottom: 2px solid rgba(184, 115, 51, 0.2);
            display: flex; align-items: center; gap: 0.6rem;
        }
        .section-icon {
            width: 28px; height: 28px; display: inline-flex; align-items: center;
            justify-content: center; border-radius: 8px; font-size: 1.1rem;
            flex-shrink: 0;
        }

        /* ‚îÄ‚îÄ‚îÄ Cards ‚îÄ‚îÄ‚îÄ */
        .cards-grid {
            display: grid; grid-template-columns: repeat(auto-fill, minmax(320px, 1fr));
            gap: 1.25rem;
        }
        .update-card {
            background: white; border-radius: 14px; padding: 1.5rem 1.6rem;
            border: 1px solid rgba(26, 58, 82, 0.06);
            box-shadow: 0 2px 12px rgba(26, 58, 82, 0.05);
            transition: all 0.35s ease; display: flex; flex-direction: column;
        }
        .update-card:hover {
            transform: translateY(-4px);
            box-shadow: 0 8px 30px rgba(26, 58, 82, 0.12);
            border-color: rgba(184, 115, 51, 0.15);
        }
        .card-meta {
            display: flex; justify-content: space-between; align-items: center;
            margin-bottom: 0.6rem; font-size: 0.8rem; color: var(--teal-accent); opacity: 0.8;
        }
        .card-source { font-weight: 600; }
        .card-date { font-style: italic; }
        .card-title {
            font-family: 'Playfair Display', serif; font-size: 1.15rem; font-weight: 700;
            color: var(--rich-blue); margin-bottom: 0.5rem; line-height: 1.35;
        }
        .card-title a {
            color: inherit; text-decoration: none; transition: color 0.3s;
        }
        .card-title a:hover { color: var(--copper); }
        .card-summary {
            font-size: 0.95rem; color: var(--rich-blue); opacity: 0.75;
            line-height: 1.6; margin-bottom: 0.8rem; flex-grow: 1;
        }
        .card-tags { display: flex; flex-wrap: wrap; gap: 0.4rem; }
        .card-tag {
            font-size: 0.72rem; padding: 0.2rem 0.6rem; border-radius: 10px;
            font-weight: 600; letter-spacing: 0.03em;
            background: rgba(44, 95, 111, 0.08); color: var(--teal-accent);
        }
        .card-tag.regulatory { background: rgba(184, 115, 51, 0.1); color: var(--copper); }
        .card-tag.ai { background: rgba(26, 58, 82, 0.1); color: var(--rich-blue); }
        .card-tag.event { background: rgba(139, 157, 131, 0.15); color: #5a6e52; }

        .no-results {
            text-align: center; padding: 3rem 1rem; color: var(--teal-accent);
            font-size: 1.15rem; display: none;
        }

        /* ‚îÄ‚îÄ‚îÄ Footer ‚îÄ‚îÄ‚îÄ */
        footer {
            background: var(--rich-blue); color: rgba(255,255,255,0.7); padding: 4rem;
            margin-top: 4rem;
        }
        .footer-container { max-width: 1100px; margin: 0 auto; }
        .footer-content {
            display: grid; grid-template-columns: 2fr 1fr 1fr 1fr; gap: 3rem;
            margin-bottom: 2rem;
        }
        .footer-brand p { font-size: 0.95rem; margin-top: 0.5rem; line-height: 1.6; }
        .footer-links h4 {
            color: white; font-family: 'Playfair Display', serif; font-size: 1.1rem;
            margin-bottom: 1rem;
        }
        .footer-links ul { list-style: none; }
        .footer-links li { margin-bottom: 0.5rem; }
        .footer-links a {
            color: rgba(255,255,255,0.6); text-decoration: none; font-size: 0.95rem;
            transition: color 0.3s;
        }
        .footer-links a:hover { color: var(--copper); }
        .footer-bottom {
            border-top: 1px solid rgba(255,255,255,0.1); padding-top: 1.5rem;
            text-align: center; font-size: 0.9rem;
        }

        /* ‚îÄ‚îÄ‚îÄ Responsive ‚îÄ‚îÄ‚îÄ */
        @media (max-width: 900px) {
            nav { padding: 1rem 1.5rem; }
            .nav-links { display: none; flex-direction: column; gap: 1rem;
                position: absolute; top: 100%; left: 0; right: 0;
                background: rgba(250,250,248,0.98); padding: 1.5rem; text-align: center;
                box-shadow: 0 8px 30px rgba(26,58,82,0.1);
            }
            .nav-links.open { display: flex; }
            .hamburger { display: flex; flex-direction: column; gap: 5px; cursor: pointer; }
            .hamburger span { width: 24px; height: 2px; background: var(--rich-blue); transition: 0.3s; }
            .hero { padding: 8rem 1.5rem 3rem; }
            .hero h1 { font-size: 2.2rem; }
            .controls { padding: 0 1.5rem; }
            .cards-grid { grid-template-columns: 1fr; }
            .section-block { padding: 0 1.5rem; }
            .footer-content { grid-template-columns: 1fr 1fr; gap: 2rem; }
            footer { padding: 2.5rem 1.5rem; }
            .sort-btn { margin-left: 0; }
        }

        @media (min-width: 901px) {
            .hamburger { display: none; }
        }
    </style>
</head>
<body>
    <div class="molecular-bg"></div>

    <!-- Navigation -->
    <nav>
        <a href="index.html" class="nav-brand">
            <img src="Cambilogics_new_logo_transparent.png" alt="CamBioLogics">
            <span class="nav-tagline">Engineering <span>Intelligence</span> into Cell & Gene Therapy</span>
        </a>
        <div class="hamburger" onclick="this.classList.toggle('active'); document.querySelector('.nav-links').classList.toggle('open')">
            <span></span><span></span><span></span>
        </div>
        <ul class="nav-links">
            <li><a href="index.html">Home</a></li>
            <li><a href="cambiologics-about-us.html">About Us</a></li>
            <li class="dropdown">
                <a href="cambiologics-platforms.html">Platforms ‚ñæ</a>
                <div class="dropdown-content">
                    <a href="auth/dashboard.html" class="dropdown-flagship">
                        <div>
                            <span class="flagship-name">CARchitect</span>
                            <span class="flagship-desc">AI-powered CAR construct design platform</span>
                        </div>
                        <div class="flagship-badges">
                            <span class="flagship-badge">Flagship</span>
                            <span class="flagship-badge-outline">AI-Powered</span>
                        </div>
                    </a>
                    <div class="dropdown-divider-label">Other Platforms</div>
                    <a href="cambiologics-predict-mab.html">PREDICT-mAb</a>
                    <a href="cambiologics-cellcipher.html">CellCipher</a>
                    <a href="cambiologics-genspy.html">GenSpy</a>
                </div>
            </li>
            <li><a href="team.html">Team</a></li>
            <li><a href="contact.html">Contact Us</a></li>
            <li><a href="industry-updates.html" class="nav-cta-updates active">Industry Updates</a></li>
        </ul>
    </nav>

    <!-- Hero -->
    <section class="hero">
        <h1>Cell & Gene Therapy <span class="highlight">Industry Updates</span></h1>
        <p class="hero-subtitle">
            Curated news, regulatory developments, AI advancements in biosciences, and upcoming events shaping the future of advanced therapies.
        </p>
    </section>

    <!-- Controls -->
    <div class="controls">
        <input type="text" class="search-box" id="searchBox" placeholder="Search by title, source, or tag‚Ä¶">
        <div class="filter-chips">
            <span class="filter-chip active" data-category="all">All</span>
            <span class="filter-chip" data-category="headline">Headlines</span>
            <span class="filter-chip" data-category="regulatory">Regulatory</span>
            <span class="filter-chip" data-category="ai">AI in Bio</span>
            <span class="filter-chip" data-category="event">Events</span>
            <button class="sort-btn" id="sortBtn">‚Üï Sort by Date</button>
        </div>
    </div>

    <!-- Top Headlines -->
    <div class="section-block" data-section="headline">
        <h2 class="section-heading"><span class="section-icon">üì∞</span> Top Headlines</h2>
        <div class="cards-grid" id="headlineCards"></div>
    </div>

    <!-- Regulatory / Policy -->
    <div class="section-block" data-section="regulatory">
        <h2 class="section-heading"><span class="section-icon">‚öñÔ∏è</span> Regulatory &amp; Policy</h2>
        <div class="cards-grid" id="regulatoryCards"></div>
    </div>

    <!-- AI in Bio / Discovery -->
    <div class="section-block" data-section="ai">
        <h2 class="section-heading"><span class="section-icon">üß†</span> AI in Bio &amp; Discovery</h2>
        <div class="cards-grid" id="aiCards"></div>
    </div>

    <!-- Events -->
    <div class="section-block" data-section="event">
        <h2 class="section-heading"><span class="section-icon">üìÖ</span> Upcoming Events &amp; Conferences</h2>
        <div class="cards-grid" id="eventCards"></div>
    </div>

    <div class="no-results" id="noResults">No results match your search. Try different keywords or clear your filters.</div>

    <!-- Footer -->
    <footer>
        <div class="footer-container">
            <div class="footer-content">
                <div class="footer-brand">
                    <img src="Cambilogics_logo_light.png" alt="CamBioLogics" style="height: 40px; width: auto; margin-bottom: 0.75rem;">
                    <p>CAR construct design platform for cell &amp; gene therapy research</p>
                </div>
                <div class="footer-links">
                    <h4>Platform</h4>
                    <ul>
                        <li><a href="auth/dashboard.html">CARchitect</a></li>
                        <li><a href="cambiologics-predict-mab.html">PREDICT-mAb</a></li>
                        <li><a href="cambiologics-cellcipher.html">CellCipher</a></li>
                        <li><a href="cambiologics-genspy.html">GenSpy</a></li>
                    </ul>
                </div>
                <div class="footer-links">
                    <h4>Company</h4>
                    <ul>
                        <li><a href="cambiologics-about-us.html">About Us</a></li>
                        <li><a href="team.html">Team</a></li>
                        <li><a href="contact.html">Contact</a></li>
                    </ul>
                </div>
                <div class="footer-links">
                    <h4>Resources</h4>
                    <ul>
                        <li><a href="industry-updates.html">Industry Updates</a></li>
                        <li><a href="#">Documentation</a></li>
                        <li><a href="#">API Reference</a></li>
                    </ul>
                </div>
            </div>
            <div class="footer-bottom">
                <p>&copy; 2026 CamBioLogics. Advancing biotechnology through AI.</p>
            </div>
        </div>
    </footer>

    <script>
    // ‚îÄ‚îÄ‚îÄ Industry Updates Data ‚îÄ‚îÄ‚îÄ
    const industryUpdates = [
        // ‚îÄ‚îÄ TOP HEADLINES ‚îÄ‚îÄ
        {
            category: "headline",
            title: "CRISPR Epigenetic Editing Turns Genes On Without Cutting DNA",
            url: "https://www.sciencedaily.com/releases/2026/01/260104202813.htm",
            source: "ScienceDaily / UNSW Sydney",
            date: "2026-01-04",
            summary: "Scientists demonstrate a gentler form of gene editing that reactivates silenced genes by removing chemical tags, opening the door to safer sickle cell disease therapies without permanent DNA cuts.",
            tags: ["Gene therapy", "CRISPR", "Epigenetics"]
        },
        {
            category: "headline",
            title: "Clemidsogene Lanparvovec (RGX-121) Faces FDA Decision for Hunter Syndrome",
            url: "https://www.cgtlive.com/view/fda-decisions-look-1h-2026",
            source: "CGT Live",
            date: "2026-02-08",
            summary: "REGENXBIO's AAV gene therapy for MPS II reaches its PDUFA date, with pivotal data showing an 82% reduction in heparan sulfate levels in CSF. A potential landmark approval for CNS-targeted gene therapy.",
            tags: ["Gene therapy", "Rare disease", "FDA"]
        },
        {
            category: "headline",
            title: "UniQure's AMT-130 Gene Therapy for Huntington Disease Receives Breakthrough Designation",
            url: "https://www.cgtlive.com/view/top-fda-gene-cell-therapy-news-2025-year-end-recap",
            source: "CGT Live",
            date: "2025-12-20",
            summary: "AMT-130 slowed disease progression by 80% at 24 months in the high-dose arm. The AAV-based therapy targeting huntingtin mRNA represents a major advance for neurodegenerative gene therapy.",
            tags: ["Gene therapy", "Neurology", "Breakthrough therapy"]
        },
        {
            category: "headline",
            title: "Nanoscope Therapeutics Submits Rolling BLA for Gene-Agnostic Retinal Therapy",
            url: "https://www.cgtlive.com/view/top-fda-gene-cell-therapy-news-2025-year-end-recap",
            source: "CGT Live",
            date: "2026-01-15",
            summary: "MCO-010, an ambient-light activatable AAV2 gene therapy for retinitis pigmentosa, could become the first gene-agnostic therapy for a retinal disorder, offering a non-surgical office-based treatment.",
            tags: ["Gene therapy", "Ophthalmology", "BLA"]
        },
        {
            category: "headline",
            title: "ASGCT and Orphan Therapeutics Accelerator Launch CGTxchange Clearinghouse",
            url: "https://www.asgct.org/news-publications/asgct-news/american-society-of-gene-cell-therapy-and-orphan-therapeutics-accelerator-partner-to-advance-and-commercialize-promising-rare-disease-treatments",
            source: "ASGCT",
            date: "2026-01-22",
            summary: "A new marketplace for deprioritized cell and gene therapies aims to rescue promising treatments abandoned by sponsors due to commercial viability concerns, connecting them with new developers.",
            tags: ["Cell therapy", "Gene therapy", "Industry"]
        },
        {
            category: "headline",
            title: "Orca Bio BLA for Orca-T Allogeneic Cell Therapy Targets April 2026 PDUFA Date",
            url: "https://www.cgtlive.com/view/fda-decisions-look-1h-2026",
            source: "CGT Live",
            date: "2026-01-10",
            summary: "Orca-T, an investigational allogeneic cell therapy for hematologic malignancies including AML, ALL, and MDS, is under FDA review with a target action date of April 6, 2026.",
            tags: ["Cell therapy", "Oncology", "FDA"]
        },
        {
            category: "headline",
            title: "Senti Bio Receives RMAT Designation for CAR-NK Cell Therapy SENTI-202",
            url: "https://www.cgtlive.com/view/top-fda-gene-cell-therapy-news-2025-year-end-recap",
            source: "CGT Live",
            date: "2025-11-18",
            summary: "SENTI-202, an allogeneic CAR-NK cell therapy for relapsed/refractory AML and MDS, gains regenerative medicine advanced therapy designation, validating next-generation engineered immune cell approaches.",
            tags: ["Cell therapy", "CAR-NK", "Oncology"]
        },
        {
            category: "headline",
            title: "Cell & Gene Therapy Start-up Financing Surges 141% in Q4 2025",
            url: "https://www.asgct.org/news-publications/landscape-report",
            source: "ASGCT Quarterly Landscape Report",
            date: "2025-12-31",
            summary: "Advanced molecular therapy start-up financing reached 14 transactions worth $557.1 million in Q4 2025, signalling renewed investor confidence in the CGT sector after a challenging funding period.",
            tags: ["Industry", "Investment", "Cell therapy"]
        },

        // ‚îÄ‚îÄ REGULATORY / POLICY ‚îÄ‚îÄ
        {
            category: "regulatory",
            title: "FDA Announces Flexible CMC Oversight Framework for Cell & Gene Therapies",
            url: "https://www.onclive.com/view/fda-outlines-flexible-approach-to-cmc-oversight-for-cell-and-gene-therapies",
            source: "OncLive / FDA CBER",
            date: "2026-01-11",
            summary: "CBER details a flexible approach to chemistry, manufacturing, and control requirements, easing Phase 2/3 cGMP mandates and commercial specification rigidity to accelerate CGT development.",
            tags: ["Regulatory", "FDA", "Manufacturing"]
        },
        {
            category: "regulatory",
            title: "FDA's 'Plausible Mechanism Pathway' for Ultra-Rare Disease Therapies",
            url: "https://ascopost.com/news/january-2026/fda-increases-flexibility-on-requirements-for-cell-and-gene-therapies/",
            source: "ASCO Post / NEJM",
            date: "2025-11-15",
            summary: "CBER Director Prasad and Commissioner Makary introduce a new regulatory pathway for personalized CGTs targeting ultra-rare conditions, inspired by the landmark bespoke CRISPR treatment of Baby KJ.",
            tags: ["Regulatory", "FDA", "Personalized medicine"]
        },
        {
            category: "regulatory",
            title: "FDA Issues Three Draft Guidance Documents for Regenerative Medicine Therapies",
            url: "https://www.healthadvances.com/insights/blog/2025-marks-technology-regulatory-and-disease-area-shifts-in-cell-and-gene-therapy",
            source: "Health Advances / FDA",
            date: "2025-09-20",
            summary: "New guidance covers expedited programs (Fast Track, RMAT, Breakthrough), post-approval monitoring requirements, and long-term safety considerations for pediatric CGT patients.",
            tags: ["Regulatory", "FDA", "Guidance"]
        },
        {
            category: "regulatory",
            title: "EU AI Act High-Risk Provisions to Impact Drug Development AI by August 2026",
            url: "https://www.drugtargetreview.com/article/192962/ai-in-drug-discovery-predictions-for-2026/",
            source: "Drug Target Review",
            date: "2026-01-20",
            summary: "The EU AI Act's high-risk provisions taking effect August 2, 2026 may classify some drug development AI systems as high-risk, creating new compliance and documentation requirements for pharma.",
            tags: ["Regulatory", "AI drug discovery", "EU AI Act"]
        },

        // ‚îÄ‚îÄ AI IN BIO / DISCOVERY ‚îÄ‚îÄ
        {
            category: "ai",
            title: "Isomorphic Labs Unveils IsoDDE ‚Äî Described as 'AlphaFold 4' for Drug Discovery",
            url: "https://www.nature.com/articles/d41586-026-00365-7",
            source: "Nature",
            date: "2026-02-10",
            summary: "DeepMind spin-off releases a proprietary drug-discovery engine that more than doubles AlphaFold 3's accuracy on difficult protein-ligand systems, predicting binding affinity and cryptic binding sites.",
            tags: ["AI drug discovery", "Protein structure", "DeepMind"]
        },
        {
            category: "ai",
            title: "DeepMind CEO Confirms AI-Designed Cancer Drug Entering Phase 1 Trials in 2026",
            url: "https://creati.ai/ai-news/2026-02-14/deepmind-ai-cancer-drug-clinical-trials-2026-demis-hassabis/",
            source: "Creati AI / WEF Davos",
            date: "2026-02-14",
            summary: "Demis Hassabis announces at Davos that Isomorphic Labs' first AI-designed cancer molecule will enter Phase 1 clinical trials in early 2026, marking a milestone for AI-originated therapeutics.",
            tags: ["AI drug discovery", "Oncology", "Clinical trials"]
        },
        {
            category: "ai",
            title: "Eli Lilly Opens TuneLab AI Suite to Select Biotech Partners",
            url: "https://www.biospace.com/business/ai-is-changing-pharmas-bottom-line-now-but-not-through-splashy-drug-discovery",
            source: "BioSpace",
            date: "2025-09-15",
            summary: "Lilly shares access to its ~$1 billion AI R&D investment through TuneLab, offering select biotechs AI-powered drug discovery tools in exchange for data-sharing partnerships.",
            tags: ["AI drug discovery", "Pharma partnership", "Data sharing"]
        },
        {
            category: "ai",
            title: "Recursion Reports Fifth Sanofi Milestone, Preliminary REC-4881 Efficacy",
            url: "https://www.drugtargetreview.com/article/192951/ai-in-drug-discovery-2025-in-review/",
            source: "Drug Target Review",
            date: "2025-12-18",
            summary: "Recursion achieves its fifth Sanofi collaboration milestone (total $134M) and reports preliminary efficacy data for REC-4881 in familial adenomatous polyposis, validating its AI-biology platform.",
            tags: ["AI drug discovery", "Clinical data", "Partnership"]
        },
        {
            category: "ai",
            title: "World Economic Forum: How AI is Reshaping Drug Discovery",
            url: "https://www.weforum.org/stories/2026/01/how-ai-is-reshaping-drug-discovery/",
            source: "World Economic Forum",
            date: "2026-01-25",
            summary: "A comprehensive WEF analysis examines AI's transformation of pharmaceutical R&D, from target identification through clinical trial optimization, as the field approaches its first potential FDA approval.",
            tags: ["AI drug discovery", "Industry analysis", "Policy"]
        },
        {
            category: "ai",
            title: "AI Drug Discovery Market Projected to Reach $8‚Äì10 Billion in 2026",
            url: "https://ardigen.com/ai-in-biotech-lessons-from-2025-and-the-trends-shaping-drug-discovery-in-2026/",
            source: "Ardigen / Industry Analysis",
            date: "2026-01-08",
            summary: "Market forecasts show AI drug discovery growing from ~$5‚Äì7B in 2025 to $8‚Äì10B in 2026, driven by record IND filings for AI-originated molecules and expanded pharma partnerships.",
            tags: ["AI drug discovery", "Market analysis", "Investment"]
        },

        // ‚îÄ‚îÄ EVENTS / CONFERENCES ‚îÄ‚îÄ
        {
            category: "event",
            title: "ASGCT 28th Annual Meeting ‚Äî Boston, MA",
            url: "https://annualmeeting.asgct.org/",
            source: "ASGCT",
            date: "2026-05-11",
            summary: "The largest cell and gene therapy scientific meeting returns with 170+ sessions, 750+ speakers, and 1,500+ posters. Workshops cover CGT manufacturing automation and homology-directed repair.",
            tags: ["Conference", "Cell therapy", "Gene therapy"]
        },
        {
            category: "event",
            title: "Advanced Therapies Week 2026 ‚Äî San Diego, CA",
            url: "https://www.phacilitate.com/advanced-therapies-week",
            source: "Phacilitate",
            date: "2026-02-09",
            summary: "The premier US cell and gene therapy partnering event brings 2,000+ leaders to San Diego for 4 days of deal-making, with 250+ speakers on clinical development, manufacturing, and commercialisation.",
            tags: ["Conference", "Cell therapy", "Gene therapy"]
        },
        {
            category: "event",
            title: "Advanced Therapies Europe 2026 ‚Äî Barcelona",
            url: "https://www.phacilitate.com/",
            source: "Phacilitate",
            date: "2026-09-07",
            summary: "Three days of deal-making and data-driven insight across cell and gene therapy in Europe, connecting developers, CDMOs, and investors at Barcelona's leading advanced therapies forum.",
            tags: ["Conference", "Cell therapy", "Gene therapy"]
        },
        {
            category: "event",
            title: "ASGCT Empowering Patients 2026: A Cell and Gene Therapies Summit",
            url: "https://www.asgct.org/events-meetings/empowering-patients-2026-a-cell-and-gene-therapies-summit",
            source: "ASGCT",
            date: "2026-03-15",
            summary: "A patient-focused summit bridging the gap between scientific innovation and patient communities, covering access, education, and advocacy in cell and gene therapy.",
            tags: ["Conference", "Patient advocacy", "Cell therapy"]
        },
        {
            category: "event",
            title: "ASGCT: Advancing Cell & Gene Therapies for Cancer",
            url: "https://www.asgct.org/events-meetings/advancing-cell-gene-therapies-for-cancer",
            source: "ASGCT",
            date: "2026-06-20",
            summary: "A focused meeting on the latest advances in CAR-T, TCR, and next-generation immune cell therapies for oncology, featuring translational research and clinical trial updates.",
            tags: ["Conference", "Oncology", "CAR-T"]
        },
        {
            category: "event",
            title: "2026 Life Sciences Forecast Summit ‚Äî AI, Next-Gen CGT, and Policy Disruption",
            url: "https://www.advi.com/insight/2026-life-sciences-forecast-ai-next-gen-cell-gene-therapy-and-policy-disruption/",
            source: "ADVI Health",
            date: "2026-01-30",
            summary: "Industry leaders convene to discuss the intersection of AI, next-generation cell and gene therapy, and evolving health policy, mapping out strategic priorities for 2026.",
            tags: ["Conference", "AI drug discovery", "Policy"]
        }
    ];

    // ‚îÄ‚îÄ‚îÄ Rendering Logic ‚îÄ‚îÄ‚îÄ
    const sections = { headline: 'headlineCards', regulatory: 'regulatoryCards', ai: 'aiCards', event: 'eventCards' };
    let activeCategory = 'all';
    let sortAsc = false; // newest first by default

    function tagClass(tag) {
        const t = tag.toLowerCase();
        if (t.includes('regulatory') || t.includes('fda') || t.includes('guidance') || t.includes('eu ai')) return 'regulatory';
        if (t.includes('ai') || t.includes('deepmind') || t.includes('protein')) return 'ai';
        if (t.includes('conference') || t.includes('event') || t.includes('summit')) return 'event';
        return '';
    }

    function renderCard(item) {
        return `<div class="update-card" data-category="${item.category}">
            <div class="card-meta">
                <span class="card-source">${item.source}</span>
                <span class="card-date">${new Date(item.date).toLocaleDateString('en-GB', { day: 'numeric', month: 'short', year: 'numeric' })}</span>
            </div>
            <h3 class="card-title"><a href="${item.url}" target="_blank" rel="noopener noreferrer">${item.title}</a></h3>
            <p class="card-summary">${item.summary}</p>
            <div class="card-tags">${item.tags.map(t => `<span class="card-tag ${tagClass(t)}">${t}</span>`).join('')}</div>
        </div>`;
    }

    function render() {
        const query = document.getElementById('searchBox').value.toLowerCase().trim();

        let filtered = industryUpdates.filter(item => {
            if (activeCategory !== 'all' && item.category !== activeCategory) return false;
            if (query) {
                const haystack = (item.title + ' ' + item.source + ' ' + item.tags.join(' ')).toLowerCase();
                return haystack.includes(query);
            }
            return true;
        });

        // Sort
        filtered.sort((a, b) => {
            const da = new Date(a.date), db = new Date(b.date);
            return sortAsc ? da - db : db - da;
        });

        // Clear all grids
        Object.values(sections).forEach(id => document.getElementById(id).innerHTML = '');

        // Hide/show sections
        if (activeCategory === 'all') {
            const grouped = {};
            filtered.forEach(item => {
                if (!grouped[item.category]) grouped[item.category] = [];
                grouped[item.category].push(item);
            });
            Object.entries(sections).forEach(([cat, id]) => {
                const block = document.querySelector(`[data-section="${cat}"]`);
                if (grouped[cat] && grouped[cat].length) {
                    block.style.display = '';
                    document.getElementById(id).innerHTML = grouped[cat].map(renderCard).join('');
                } else {
                    block.style.display = 'none';
                }
            });
        } else {
            Object.entries(sections).forEach(([cat, id]) => {
                const block = document.querySelector(`[data-section="${cat}"]`);
                if (cat === activeCategory) {
                    block.style.display = '';
                    document.getElementById(id).innerHTML = filtered.map(renderCard).join('');
                } else {
                    block.style.display = 'none';
                }
            });
        }

        document.getElementById('noResults').style.display = filtered.length === 0 ? 'block' : 'none';
    }

    // ‚îÄ‚îÄ‚îÄ Event Listeners ‚îÄ‚îÄ‚îÄ
    document.getElementById('searchBox').addEventListener('input', render);

    document.querySelectorAll('.filter-chip').forEach(chip => {
        chip.addEventListener('click', () => {
            document.querySelectorAll('.filter-chip').forEach(c => c.classList.remove('active'));
            chip.classList.add('active');
            activeCategory = chip.dataset.category;
            render();
        });
    });

    document.getElementById('sortBtn').addEventListener('click', () => {
        sortAsc = !sortAsc;
        document.getElementById('sortBtn').textContent = sortAsc ? '‚Üë Oldest First' : '‚Üì Newest First';
        render();
    });

    // Initial render
    render();
    </script>
</body>
</html>
